Translational Development Acquisition Corp.

Overview

Compare with another stock.

• TickerTDAC on Nasdaq¹
• IndustryBlank Checks¹
• HeadquartersNew York, New York¹
• Business address52 E 83Rd St., New York, Ny 10028³
• Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company³

See how the biggest companies compare on our leaderboards

The registration statement (File No. 333-282763) (the “Registration Statement”) for our initial public offering was declared effective on December 20, 2024 (the “IPO”). On December 24, 2024, we consummated the IPO of 17,250,000 units (the “Units”), which includes the full exercise of the underwriter’s over-allotment option. Each Unit consists of one Class A ordinary share (the “Ordinary Share”) and one-half of one redeemable warrant (the “Warrant”), each whole Warrant entitling the holder thereof to purchase one Ordinary Share for $11.50 per share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $172,500,000.⁴ From its latest annual report

Corporate structure

Translational Development Acquisition Corp. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Translational Development Acquisition Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Properties, in its own words

We currently maintain our executive offices at 52 E. 83rd Street, New York, New York 10028. We consider our current office space adequate for our current operations.

Item 2 of the 10-K filed Mar 30, 2026.⁴

Leadership

Who has led Translational Development Acquisition Corp., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerMichael B. Hoffman Dec 20, 2024 to now¹⁰
• ChairMichael B. Hoffman May 29, 2026 to now¹¹
• Chief financial officerAvanindra Das Dec 20, 2024 to now¹²

Timeline

1. Jul 27, 20268-K Entered a material agreement; Unregistered sale of shares¹⁶
2. Jul 8, 20268-K Other events¹⁷
3. Jun 23, 20268-K Other events¹⁸
4. Jun 18, 20268-K Entered a material agreement; Bylaws or fiscal year changed; Shareholder vote¹⁹
5. Jun 12, 20268-K Unregistered sale of shares²⁰
6. May 27, 20268-K Entered a material agreement; Regulation FD disclosure²¹
7. Aug 14, 20258-K New debt or obligation; Other events²²
8. Feb 14, 20258-K Other events²³
9. Dec 31, 20248-K Other events²⁴
10. Dec 27, 20248-K Entered a material agreement; Unregistered sale of shares; Executive or director change²⁵
11. Dec 20, 2024New chief executive Michael B. Hoffman becomes CEO¹⁰

Filings

68 filings to the SEC since October 2021: 4 annual reports, 5 quarterly reports, 10 major events, 8 insider forms, 16 large holders, 25 other. The latest 20:

1. Aug 14, 2026SCHEDULE 13G EDGAR
2. Aug 14, 2026SCHEDULE 13G/A EDGAR
3. Aug 14, 202610-Q EDGAR
4. Aug 12, 2026SCHEDULE 13G/A EDGAR
5. Jul 27, 2026425 EDGAR
6. Jul 27, 20268-K EDGAR
7. Jul 16, 2026SCHEDULE 13G/A EDGAR
8. Jul 8, 20268-K EDGAR
9. Jun 23, 2026DEFA14A EDGAR
10. Jun 23, 2026425 EDGAR
11. Jun 23, 20268-K EDGAR
12. Jun 18, 20268-K EDGAR
13. Jun 12, 20268-K EDGAR
14. Jun 2, 2026SCHEDULE 13G EDGAR
15. May 29, 20264 OWNERSHIP DOCUMENT EDGAR
16. May 28, 2026DEFA14A EDGAR
17. May 27, 2026DEF 14A EDGAR
18. May 27, 2026425 EDGAR
19. May 27, 20268-K EDGAR
20. May 15, 202610-Q EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Linden Capital L.P.SCHEDULE 13G/A, 2 filings Jun 2, 2026 to Aug 14, 2026²⁶
• METEORA CAPITAL, LLCSCHEDULE 13G, 1 filing Aug 14, 2026²⁷
• Goldman SachsSCHEDULE 13G/A, 2 filings May 13, 2026 to Aug 12, 2026²⁸
• WOLVERINE ASSET MANAGEMENT LLCSCHEDULE 13G/A, 4 filings May 1, 2025 to Jul 16, 2026²⁹
• Bank of MontrealSCHEDULE 13G/A, 2 filings May 8, 2025 to Jul 31, 2025³⁰
• AQR CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 2 filings Feb 14, 2025 to May 14, 2025³¹
• HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDSCHEDULE 13G/A, 2 filings Feb 14, 2025 to May 14, 2025³²
• Magnetar Financial LLCSCHEDULE 13G, 1 filing Jan 29, 2025³³

SEC filer profile

How Translational Development Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARTranslational Development Acquisition Corp.¹
• CIK0001926599
• Employer ID (EIN)00-0000000⁴
• Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company⁴
• Incorporated inCayman Islands⁴
• Fiscal year endsDecember 31¹
• Industry code (SIC)6770 Blank Checks¹
• SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance¹
• Business address52 E 83Rd St., New York, NY 10028¹
• Phone(413) 204-2769¹
• Shares outstanding17,250,000 Common Class A shares; 4,657,500 Common Class B shares as of Mar 30, 2026⁴
• Public float$177.7M as of Jun 30, 2025⁴
• AuditorWithumSmith+Brown, PC, New York, New York PCAOB ID 100; no auditor attestation of internal control over financial reporting⁴
• On EDGAR sinceJun 13, 2022¹
• Filings79 in all: 425 (14), 8-K (10), SCHEDULE 13G (8), SCHEDULE 13G/A (8), 3 (7), 10-Q (5), CORRESP (4), 10-K (2)¹
  All 23 form types

  10-K/A (2), DEFA14A (2), DRS (2), S-1 (2), S-1/A (2), UPLOAD (2), 4 (1), 424B4 (1), 8-A12B (1), CERT (1), DEF 14A (1), DRS/A (1), EFFECT (1), PRE 14A (1), SEC STAFF ACTION (1)

• Latest filingsAnnual report (10-K) Mar 30, 2026
  Quarterly report (10-Q) Aug 14, 2026
  Proxy statement (DEF 14A) May 27, 2026
  Latest 8-K (8-K) Jul 27, 2026

Securities registered for trading

From the cover page of the 10-K filed Mar 30, 2026 (Section 12(b) of the Exchange Act).⁴

Risk factors and legal proceedings

Legal proceedings

We may be subject to legal proceedings, investigations and claims incidental to the conduct of our business from time to time. We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition, or results of operations.

The opening of Item 3, Legal Proceedings.⁴